Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-014771·Edesa Biotech, Inc.
Schedule 13G ownership disclosure
EDESA BIOTECH INC
Common Stock, without par value · CUSIP: 27966L306
Event date: 2025-02-13
- Filing-level shares
- 0.00
- Percent of class
- 0%
- Thomas A. Satterfield, Jr.
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-014771
- Form type
- SCHEDULE 13G/A
- Filer
- Edesa Biotech, Inc.
- CIK
- CIK 1540159
- Filed
- Feb 18, 2025
- Reporting period
- Feb 13, 2025
- Description
- Schedule 13G beneficial ownership